Robeco Institutional Asset Management B.V. Boosts Stock Position in Waters Co. (NYSE:WAT)

Robeco Institutional Asset Management B.V. raised its position in shares of Waters Co. (NYSE:WAT - Free Report) by 1,095.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 200,705 shares of the medical instruments supplier's stock after purchasing an additional 183,916 shares during the period. Robeco Institutional Asset Management B.V. owned 0.34% of Waters worth $66,078,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in Waters in the 3rd quarter worth about $33,000. Exchange Traded Concepts LLC bought a new stake in shares of Waters in the fourth quarter valued at approximately $35,000. VisionPoint Advisory Group LLC raised its position in shares of Waters by 300.0% in the third quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 108 shares during the period. Wetzel Investment Advisors Inc. purchased a new stake in shares of Waters during the 4th quarter valued at approximately $39,000. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Waters in the 4th quarter worth approximately $41,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. TD Cowen increased their target price on Waters from $350.00 to $358.00 and gave the stock a "hold" rating in a research report on Wednesday, May 8th. Robert W. Baird cut their target price on Waters from $319.00 to $312.00 and set a "neutral" rating for the company in a research note on Wednesday, May 8th. Stifel Nicolaus upped their price target on Waters from $330.00 to $332.00 and gave the company a "hold" rating in a research report on Wednesday, May 8th. Barclays cut their price objective on shares of Waters from $300.00 to $295.00 and set an "underweight" rating for the company in a research report on Wednesday, May 8th. Finally, Evercore ISI boosted their price objective on shares of Waters from $320.00 to $340.00 and gave the company an "in-line" rating in a research note on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating and ten have given a hold rating to the stock. Based on data from MarketBeat.com, Waters currently has an average rating of "Hold" and an average target price of $305.78.

Insider Activity at Waters

In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total value of $1,446,560.00. Following the completion of the sale, the director now owns 14,716 shares of the company's stock, valued at $5,321,894.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the business's stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the completion of the sale, the director now directly owns 14,716 shares of the company's stock, valued at $5,321,894.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Linda Baddour sold 500 shares of the firm's stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the transaction, the director now directly owns 2,250 shares in the company, valued at $799,965. The disclosure for this sale can be found here. 0.82% of the stock is currently owned by insiders.

Waters Price Performance

WAT stock traded down $4.56 during midday trading on Friday, reaching $355.95. The company had a trading volume of 387,752 shares, compared to its average volume of 483,144. The firm has a 50-day moving average price of $333.64 and a 200-day moving average price of $316.71. The company has a debt-to-equity ratio of 1.60, a current ratio of 1.94 and a quick ratio of 1.30. The company has a market capitalization of $21.11 billion, a P/E ratio of 34.93, a P/E/G ratio of 5.66 and a beta of 0.98. Waters Co. has a 1 year low of $231.90 and a 1 year high of $367.21.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.10 by $0.11. Waters had a net margin of 20.75% and a return on equity of 66.59%. The company had revenue of $636.80 million during the quarter, compared to analyst estimates of $635.57 million. During the same period in the previous year, the business earned $2.49 earnings per share. The firm's quarterly revenue was down 7.0% compared to the same quarter last year. On average, research analysts anticipate that Waters Co. will post 11.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.